YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
65 hedge funds and large institutions have $342M invested in Y-mAbs Therapeutics in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+6
Holders Change %
+10.17%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
28
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$22.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.6M |
| 4 |
BlackRock
New York
|
+$4.45M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.47M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$5.67M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.03M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$686K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$256K |
| 5 |
Citigroup
New York
|
-$138K |
